Savara Inc Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures
Savara Inc (SVRA) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures of 3.24 million shares for the 3-month period ending 2013-06-30, per its 10-Q filed 2013-08-05.
Discontinued › Shareholders' Equity
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod · last filed 2013-08-05
- Savara Inc share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2013-06-30 was 3.24M shares.
- Savara Inc share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2013-03-31 was 484.30K shares.
- Savara Inc share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2012-09-30 was 934.00K shares, a 21.69% increase year-over-year.
- Savara Inc share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2012-06-30 was 0.00 shares, a 100.00% decline year-over-year.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 9 month |
|---|---|---|---|
| 2013-06-30 | 3.24M shares 10-Q · filed 2013-08-05 | 3.72M shares 10-Q · filed 2013-08-05 | |
| 2013-03-31 | 484.30K shares 10-Q · filed 2013-05-15 | ||
| 2012-09-30 | 934.00K shares 10-Q · filed 2012-11-05 | 934.00K shares derived: sum of 2 quarters · filed 2013-08-05 | 934.00K shares 10-Q · filed 2012-11-05 |
| 2012-06-30 | 0.00 shares 10-Q · filed 2013-08-05 | 0.00 shares 10-Q · filed 2013-08-05 | |
| 2012-03-31 | 0.00 shares 10-Q · filed 2013-05-15 | ||
| 2011-09-30 | 767.50K shares 10-Q · filed 2012-11-05 | 936.30K shares derived: sum of 2 quarters · filed 2012-11-05 | 1.18M shares 10-Q · filed 2012-11-05 |
| 2011-06-30 | 168.81K shares 10-Q · filed 2012-08-06 | 413.46K shares 10-Q · filed 2012-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B |